Literature DB >> 15914697

Spatial orientation of the antagonist granisetron in the ligand-binding site of the 5-HT3 receptor.

Dong Yan1, Michael M White.   

Abstract

The serotonin type 3 receptor (5-HT(3)R) is a member of the cys-loop ligand-gated ion channel (LGIC) superfamily. Like almost all membrane proteins, high-resolution structural data are unavailable for this class of receptors. We have taken advantage of the high degree of homology between LGICs and the acetylcholine binding protein (AChBP) from the freshwater snail Lymnea stagnalis, for which high-resolution structural data are available, to create a structural model for the extracellular (i.e., ligand-binding) domain of the 5-HT(3)R and to perform a series of ligand docking experiments to delineate the architecture of the ligand-binding site. Structural models were created using homology modeling with the AChBP as a template. Docking of the antagonist granisetron was carried out using a Lamarckian genetic algorithm to produce models of ligand-receptor complexes. Two energetically similar conformations of granisetron in the binding site were obtained from the docking simulations. In one model, the indazole ring of granisetron is near Trp90 and the tropane ring is near Arg92; in the other, the orientation is reversed. We used double-mutant cycle analysis to determine which of the two orientations is consistent with experimental data and found that the data are consistent with the model in which the indazole ring of granisetron interacts with Arg92 and the tropane ring interacts with Trp90. The combination of molecular modeling with double-mutant cycle analysis offers a powerful approach for the delineation of the architecture of the ligand-binding site.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15914697     DOI: 10.1124/mol.105.011957

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  20 in total

1.  Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.

Authors:  M Lochner; S C R Lummis
Journal:  Biophys J       Date:  2010-04-21       Impact factor: 4.033

2.  Serotonin and NMDA glutamate receptor antagonists selectively impair the reactivation of associative memory in the common snail.

Authors:  S V Solntseva; V P Nikitin
Journal:  Neurosci Behav Physiol       Date:  2008-08-16

3.  Molecular actions of smoking cessation drugs at α4β2 nicotinic receptors defined in crystal structures of a homologous binding protein.

Authors:  Bert Billen; Radovan Spurny; Marijke Brams; René van Elk; Soledad Valera-Kummer; Jerrel L Yakel; Thomas Voets; Daniel Bertrand; August B Smit; Chris Ulens
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-22       Impact factor: 11.205

Review 4.  Allosteric modulation of glycine receptors.

Authors:  Gonzalo E Yevenes; Hanns Ulrich Zeilhofer
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

5.  Mapping spatial relationships between residues in the ligand-binding domain of the 5-HT3 receptor using a molecular ruler.

Authors:  Heather L Nyce; Spencer T Stober; Cameron F Abrams; Michael M White
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

Review 6.  The 5-HT3 receptor as a therapeutic target.

Authors:  Andrew J Thompson; Sarah C R Lummis
Journal:  Expert Opin Ther Targets       Date:  2007-04       Impact factor: 6.902

Review 7.  Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.

Authors:  Tina K Machu
Journal:  Pharmacol Ther       Date:  2011-02-26       Impact factor: 12.310

8.  Ondansetron and granisetron binding orientation in the 5-HT(3) receptor determined by unnatural amino acid mutagenesis.

Authors:  Noah H Duffy; Henry A Lester; Dennis A Dougherty
Journal:  ACS Chem Biol       Date:  2012-08-15       Impact factor: 5.100

Review 9.  5-HT3 receptors.

Authors:  A J Thompson; S C R Lummis
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 10.  The 5-HT3 receptor--the relationship between structure and function.

Authors:  Nicholas M Barnes; Tim G Hales; Sarah C R Lummis; John A Peters
Journal:  Neuropharmacology       Date:  2008-08-12       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.